Endobronchial Valves in Treatment of Persistent Air Leak: European Case-Series Study and Best Practice Recommendations - From an Expert Panel

被引:1
|
作者
Smesseim, Illaa [1 ]
Morin-Thibault, Louis-Vincent [2 ]
Herth, Felix J. F. [3 ,4 ]
Tonkin, James [5 ]
Shah, Pallav L. [5 ]
Slebos, Dirk-Jan [6 ]
Koster, David T. [6 ]
Dickhoff, Chris [7 ,8 ]
Daniels, Johannes Marlene Andreas [9 ]
Annema, Jouke [9 ]
Bonta, Peter [9 ]
机构
[1] Antoni van Leeuwenhoek Hosp, Dept Thorac Oncol, Amsterdam, Netherlands
[2] CHU Quebec, Dept Pulm Dis, Quebec City, PQ, Canada
[3] Thoraxklin Heidelberg, Dept Pulm Dis, Heidelberg, Germany
[4] Translat Lung Res Ctr Heidelberg, Heidelberg, Germany
[5] Chelsea & Westminster Hosp, Dept Pulm Dis, London, England
[6] Univ Groningen, Univ Med Ctr Groningen, Dept Pulm Dis, Groningen, Netherlands
[7] Amsterdam UMC Locat Vrije Univ Amsterdam, Dept Cardiothorac Surg, Amsterdam, Netherlands
[8] Canc Ctr Amsterdam, Canc Treatment & Qual Life, Amsterdam, Netherlands
[9] Univ Amsterdam, Amsterdam Univ, Med Ctr, Dept Pulmonol, Amsterdam, Netherlands
关键词
Persistent air leak; Pneumothorax; Endobronchial valve; Chest drainage; Pleurodesis; LUNG-VOLUME REDUCTION; SPONTANEOUS PNEUMOTHORAX; BRONCHOPLEURAL FISTULAS; PULMONARY RESECTION; TALC PLEURODESIS; MANAGEMENT; DRAINAGE;
D O I
10.1159/000539573
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Introduction: Persistent air leak (PAL) is associated with prolonged hospitalization, high morbidity and increased treatment costs. Conservative treatment consists of observation, chest tube drainage, and pleurodesis. Guidelines recommend surgical evaluation if air leak does not respond after 3-5 days. One-way endobronchial valves (EBV) have been proposed as a treatment option for patients with PAL in which surgical treatment is not feasible, high risk or has failed. We aimed to provide a comprehensive overview of reported EBV use for PAL and issue best practice recommendations based on multicenter experience. Methods: We conducted a retrospective observational case-series study at four different European academic hospitals and provided best practice recommendations based on our experience. A systematic literature review was performed to summarize the current knowledge on EBV in PAL. Results: We enrolled 66 patients, male (66.7%), median age 59.5 years. The most common underlying lung disease was chronic obstructive pulmonary disease (39.4%) and lung cancer (33.3%). The median time between pneumothorax and valve placement was 24.5 days (interquartile range: 14.0-54.3). Air leak resolved in 40/66 patients (60.6%) within 30 days after EBV treatment. Concerning safety outcome, no procedure-related mortality was reported and complication rate was low (6.1%). Five patients (7.6%) died in the first 30 days after intervention. Conclusion: EBV placement is a treatment option in patients with PAL. In this multicenter case-series of high-risk patients not eligible for lung surgery, we show that EBV placement resulted in air leak resolution in 6 out of 10 patients with a low complication rate. Considering the minimally invasive nature of EBV to treat PAL as opposed to surgery, further research should investigate if EBV treatment should be expanded in low to intermediate risk PAL patients.
引用
收藏
页码:544 / 562
页数:19
相关论文
共 34 条
  • [31] A Self-Controlled Case-Series Study To Assess the Effect of Orlistat on the Risk of Idiopathic Acute Liver Injury, Using Data from the United Kingdom General Practice Research Database
    Langham, Julia
    Douglas, Ian
    Brauer, Ruth
    Bhaskaran, Krishnan
    Smeeth, Liam
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S306 - S306
  • [32] Reflections and best practice recommendations for interdisciplinary working: a case study on the identification of the determinants of addiction from the Addiction and Lifestyles In Contemporary Europe Reframing Addictions Project (ALICE RAP)
    Gell, Lucy
    McLeod, Jane
    Holmes, John
    Everson-Hock, Emma
    Buehringer, Gerhard
    Lingford-Hughes, Anne
    Neumann, Maria
    Meier, Petra
    LANCET, 2014, 384 : 13 - 13
  • [33] The impact of patient characteristics and disease-specific factors on first-line treatment decisions for BRAF-mutated melanoma: results from a European expert panel study
    Ascierto, Paolo A.
    Bastholt, Lars
    Ferrucci, Pier F.
    Hansson, Johan
    Marquez Rodas, Ivan
    Payne, Miranda
    Robert, Caroline
    Thomas, Luc
    Utikal, Jochen S.
    Wolter, Pascal
    Kudlac, Amber
    Tuson, Harriet
    McKendrick, Jan
    MELANOMA RESEARCH, 2018, 28 (04) : 333 - 340
  • [34] Wound Healing Rates of chronic Wounds treated with a transforming Powder Dressing (Altrazeal) compared to Best Practice - Data from a retrospective Case Study measured by the European Wound Registry
    Kirsten, Natalia
    Augustin, Matthias
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 : 176 - 176